Xylem (XYL) financial statements
+217.1%since 2009
- FY2025 revenue
- $9.0B▲ +5.5%
- FY2025 net income
- $957M▲ +7.5%
- FY2025 diluted EPS
- $3.92▲ +7.4%
- FY2025 free cash flow
- $910M▼ −3.4%
Xylem income statement
| USD millions | FY2025 | FY2024 | FY2023 |
|---|---|---|---|
| Period ended | 31 Dec 2025 | 31 Dec 2024 | 31 Dec 2023 |
| Revenue | 9,035 | 8,562 | 7,364 |
| Gross profit | 3,475 | 3,212 | 2,717 |
| Operating income | 1,223 | 1,009 | 652 |
| Pretax income | 1,181 | 1,087 | 635 |
| Net income | 957 | 890 | 609 |
| Diluted earnings per share | 3.92 | 3.65 | 2.79 |
Xylem balance sheet
| USD millions | FY2025 | FY2024 | FY2023 |
|---|---|---|---|
| Period ended | 31 Dec 2025 | 31 Dec 2024 | 31 Dec 2023 |
| Cash and cash equivalents | 1,479 | 1,121 | 1,019 |
| Total assets | 17,634 | 16,493 | 16,112 |
| Total liabilities | 5,885 | 5,611 | 5,936 |
| Total equity | 11,491 | 10,647 | 10,176 |
| Long-term debt | 1,408 | 1,978 | 2,268 |
Xylem cash flow statement
| USD millions | FY2025 | FY2024 | FY2023 |
|---|---|---|---|
| Period ended | 31 Dec 2025 | 31 Dec 2024 | 31 Dec 2023 |
| Operating cash flow | 1,241 | 1,263 | 837 |
| Capital expenditure | -331 | -321 | -271 |
| Free cash flow (derived) | 910 | 942 | 566 |
| Dividends paid | -391 | -350 | -299 |
| Share repurchases | -15 | -20 | -25 |
Quarterly highlights
| USD millions | Q3 FY2026 | Q2 FY2026 | Q1 FY2026 | Q4 FY2025 |
|---|---|---|---|---|
| Period ended | 30 Sep 2026 | 30 Jun 2026 | 31 Mar 2026 | 31 Dec 2025 |
| Revenue (derived) | 2,201 | 2,336 | 2,125 | 2,397 |
| Operating income (derived) | 385 | 390 | 244 | 353 |
| Net income (derived) | 291 | 263 | 193 | 335 |
| Diluted earnings per share | 1.25 | 1.11 | 0.79 | n/a |
| Operating cash flow (derived) | 331 | 290 | 108 | 543 |
| Total assets | 17,326 | 17,342 | 16,954 | 17,634 |
Xylem major shareholders
| Holder | Share of class | Shares | Filed |
|---|---|---|---|
| Vanguard Capital Management | 7.5% | 18,193,892 | 30 April 2026 |
| Vanguard Portfolio Management | 5.3% | 12,800,726 | 30 April 2026 |
Xylem 10-K and SEC filings
| Filed | Form | Type | Description |
|---|---|---|---|
| 27 October 2026 | 10-Q | Quarterly report | Quarterly report |
| 27 October 2026 | 8-K | Current report | Current report |
| 29 September 2026 | 8-K | Current report | Current report |
| 8 September 2026 | 8-K | Current report | Current report |
| 18 August 2026 | 8-K | Current report | Current report |
| 13 August 2026 | 8-K | Current report | Current report |
| 28 July 2026 | 10-Q | Quarterly report | Quarterly report |
| 28 July 2026 | 8-K | Current report | Current report |
Common questions
What was Xylem's revenue in fiscal 2025?
Xylem reported $9.0 billion in revenue for fiscal 2025, the year ended 31 December 2025, up 5.5% from fiscal 2024.
What was Xylem's net income in fiscal 2025?
Xylem reported net income of $957 million for fiscal 2025, the year ended 31 December 2025, up 7.5% from fiscal 2024. Diluted earnings per share were $3.92.
What was Xylem's free cash flow in fiscal 2025?
Xylem had $910 million in free cash flow in fiscal 2025. Operating cash flow was $1.2 billion and capital expenditure was $331 million.
What were Xylem's total assets at the end of fiscal 2025?
Xylem reported total assets of $17.6 billion at the end of fiscal 2025, the year ended 31 December 2025.
How much Xylem history do I get?
Every account gets the full history, annual and quarterly, with first reported values and as of dates.
Start with a free key
Free $10 credits every month, no card.Free $10 credits a month, no card.